CompletedNCT01528774
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers
Studying Melanoma of soft tissue
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wolfram Samlowski
- Principal Investigator
- Wolfram Samlowski, MDComprehensive Cancer Centers of Nevada
- Intervention
- Blood Draw(other)
- Enrollment
- 150 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2016
Study locations (1)
- Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, United States
Collaborators
TrueCells, LLC · Comprehensive Cancer Centers of Nevada · University of Pittsburgh
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01528774 on ClinicalTrials.govOther trials for Melanoma of soft tissue
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06942143An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid TumorsGuangzhou FineImmune Biotechnology Co., LTD.
- RECRUITINGPHASE1NCT06889766NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and SarcomaCentre Hospitalier Universitaire Vaudois
- ACTIVE NOT RECRUITINGNANCT05121545Proton Pencil Beam Scanning GRID for Treatment of Bulky TumorsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- RECRUITINGNCT05231655Ex VIvo DEtermiNed Cancer TherapySheffield Teaching Hospitals NHS Foundation Trust